Recombinant Mouse Leptin R Fc Chimera Protein

• Supplier: R&D Systems
• Catalog: 497-LR
• Category: Protein
• Prices: $349.00
• Sizes: 100 µg
• Species Reactivities: Mouse
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived Mouse Leptin R (Ala20-Gly839) Accession # Q3US58 IIEGRDMD Human IgG 1 (Pro100-Lys330) 6-His tag N-terminus C-terminus
• Purity: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Bioactivity: Measured by its ability to inhibit Leptin-dependent proliferation of BaF3 mouse pro‑B cells transfected with human Leptin R. The ED 50 for this effect is 0.004-0.015 µg/mL in the presence of 1 ng/mL recombinant mouse Leptin.
• Endotoxin: <0.01 EU per 1 μg of the protein by the LAL method.
• SwissProt/Accession: Q3US58
• Gene: Lepr
• Sequence: Ala20

Product References

Leptin receptor signaling in T cells is required for Th17 differentiation. - Leptin receptor signaling in T cells is required for Th17 differentiation.

Reis BS, Lee K, Fanok MH, Mascaraque C, Amoury M, Cohn LB, Rogoz A, Dallner OS, Moraes-Vieira PM, Domingos AI, Mucida D. J Immunol. 2015 Jun 1;194(11):5253-60.

Leptin exacerbates sepsis-mediated morbidity and mortality. - Leptin exacerbates sepsis-mediated morbidity and mortality.

Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, Castro PR, Maratos-Flier E, Parikh SM, Karumanchi SA, Yano K. J Immunol. 2010 Jul 1;185(1):517-24.

Soluble receptor inhibits leptin transport. - Soluble receptor inhibits leptin transport.

Tu H, Kastin AJ, Hsuchou H, Pan W. J Cell Physiol. 2008 Feb;214(2):301-5.

High circulating leptin receptors with normal leptin sensitivity in - High circulating leptin receptors with normal leptin sensitivity in

Cohen SE, Kokkotou E, Biddinger SB, Kondo T, Gebhardt R, Kratzsch J, Mantzoros CS, Kahn CR. J Biol Chem. 2007 Aug 10;282(32):23672-8. Epub 2007 Jun 7.

Leptin neutralization interferes with pathogenic T cell autoreactivity in - Leptin neutralization interferes with pathogenic T cell autoreactivity in

De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, Zappacosta S, Matarese G. J Clin Invest. 2006 Feb;116(2):447-55. Epub 2006 Jan 12.

Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. - Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist.

Dobrzanski P, Hunter K, Jones-Bolin S, Chang H, Robinson C, Pritchard S, Zhao H, Ruggeri B. Cancer Res. 2004 Feb 1;64(3):910-9.

BiaCore analysis of leptin-leptin receptor interaction: evidence for 1:1 - BiaCore analysis of leptin-leptin receptor interaction: evidence for 1:1

Mistrik P, Moreau F, Allen JM. Anal Biochem. 2004 Apr 15;327(2):271-7.